| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/11/2005 | WO2005073390A2 L-amino acid-producing microorganism and method for producing l-amino acid |
| 08/11/2005 | WO2005073384A2 Human soluble neuropilin-1 primary polyadenylation signal and uses thereof |
| 08/11/2005 | WO2005073383A2 HETERODIMERIC FOLLICLE STIMULATING HORMONE-Fc (FSH-Fc) FUSION PROTEINS FOR THE TREATMENT OF INFERTILITY |
| 08/11/2005 | WO2005073379A1 Carcinostatic method using brca1-bard1 pathway |
| 08/11/2005 | WO2005073374A1 Novel tumor antigen protein and utilization of the same |
| 08/11/2005 | WO2005073372A1 Novel taste sensation-modifying peptide nas, dna thereof and use of the same |
| 08/11/2005 | WO2005073371A2 Enhanced secretion/retention of growth hormone releasing hormone (ghrh) from muscle cells by species-specific signal peptide |
| 08/11/2005 | WO2005073251A1 Serotonin receptor |
| 08/11/2005 | WO2005073249A1 Corticotropin-releasing factor receptor 1 (crfr1) agonist polypeptides |
| 08/11/2005 | WO2005073248A1 Peptides for treatment of autoimmune diseases |
| 08/11/2005 | WO2005073246A2 Method for preparing kl4 lung surfactant |
| 08/11/2005 | WO2005073245A1 Method for crystallization of proteins using polysaccharides |
| 08/11/2005 | WO2005072893A1 Functionalized colloidal metal compositions and methods |
| 08/11/2005 | WO2005072767A1 Agent for improving sugar metaboic function |
| 08/11/2005 | WO2005072766A2 Peptides that bind to hsp90 proteins |
| 08/11/2005 | WO2005072419A2 Gastrointestinal proliferative factor and uses thereof |
| 08/11/2005 | WO2005072417A2 Vascular endothelial growth factors and methods of their use |
| 08/11/2005 | WO2005072403A2 Bone morphogenic protein binding peptide |
| 08/11/2005 | WO2005072388A2 Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone |
| 08/11/2005 | WO2005072385A2 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use |
| 08/11/2005 | WO2005072347A2 Inositol 1,4,5- trisphosphate receptor mutants and uses thereof |
| 08/11/2005 | WO2005072340A2 Novel polynucleotides encoding polypeptides and methods using same |
| 08/11/2005 | WO2005072277A2 Amidated parathyroid hormone fragments and uses thereof |
| 08/11/2005 | WO2005072270A2 Methods and compositons for treating cancer |
| 08/11/2005 | WO2005072254A2 Modulation of sulfate permease for photosynthetic hydrogen production |
| 08/11/2005 | WO2005072223A2 Engineered proteins, and methods of making and using |
| 08/11/2005 | WO2005072141A2 Peptide inhibitors of rhoa signaling |
| 08/11/2005 | WO2005072129A2 Production of host cells containing mutiple integrating vectors by serial transduction |
| 08/11/2005 | WO2005072076A2 Novel nucleic acids and polypeptides |
| 08/11/2005 | WO2005072057A2 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |
| 08/11/2005 | WO2005072049A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of endometriosis |
| 08/11/2005 | WO2005072045A2 The combined use of glp-1 agonists and gastrin for regulating blood glucose levels |
| 08/11/2005 | WO2005066204A3 Neutralizing epitope-based growth enhancing vaccine |
| 08/11/2005 | WO2005056046A3 Methods for treating inflammation using thyroid stimulating hormone |
| 08/11/2005 | WO2005049647A3 Compositions comprising melittin-derved peptides and methods for the potentiation of immune responses against target antigens |
| 08/11/2005 | WO2005042565A3 Cyclin groove inhibitors |
| 08/11/2005 | WO2005040375A9 A fungal immuromodulatory protein produced by microorganisme and uses thereof |
| 08/11/2005 | WO2005040368A3 Crystals of an aurora-a tpx2 complex, tpx2 binding site of aurora-a, aurora-a ligands and their use |
| 08/11/2005 | WO2005040344A3 Generation of stabilized proteins by combinatorial consensus mutagenesis |
| 08/11/2005 | WO2005038017A3 Prevention of incorporation of non-standard amino acids into protein |
| 08/11/2005 | WO2005030965A3 Expansin polypeptides |
| 08/11/2005 | WO2005030804A3 A method of modulating cell survival, differentiation and/or synaptic plasticity |
| 08/11/2005 | WO2005026392A3 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes |
| 08/11/2005 | WO2005019457A3 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY |
| 08/11/2005 | WO2005012356A3 Gelatin capsules |
| 08/11/2005 | WO2005002501A3 Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same |
| 08/11/2005 | WO2005001099A3 Protein expression system |
| 08/11/2005 | WO2005000877A3 Novel melanocortin receptor templates, peptides, and use thereof |
| 08/11/2005 | WO2004101607A3 Comparative ligand mapping from mhc class i positive cells |
| 08/11/2005 | WO2004099376A3 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
| 08/11/2005 | WO2004094602A3 Combinatorial surface chip compositions for selection, differentiation and propagation of cells |
| 08/11/2005 | WO2004094463A3 Peptide inhibitors of autophosphorylation protein kinases |
| 08/11/2005 | WO2004083394A3 Human g protein-coupled receptors and modulators thereof for the treatment of inflammatory disorders |
| 08/11/2005 | WO2004066917A3 Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites |
| 08/11/2005 | WO2004057021A3 Molecular methods and compositions for detecting and quantifying respiratory viruses |
| 08/11/2005 | WO2004043407A3 Methods and products for treating staphylococcal infections |
| 08/11/2005 | WO2004043382A3 Enhanced variants of erythropoietin and methods of use |
| 08/11/2005 | WO2004042063A8 Pharmaceutical composition for preparing a medicine for treating and/or preventing a pathology related to an obsessive behaviour or obesity |
| 08/11/2005 | WO2004039940A3 Polynucleotide encoding novel human g-protein coupled receptors, and splice variants thereof |
| 08/11/2005 | WO2004033636A3 Protein modification and maintenance molecules |
| 08/11/2005 | WO2004018702A3 Nphp nucleic acids and proteins |
| 08/11/2005 | WO2004007667A3 Polynucleotide and polypeptide fat metabolism regulators and uses thereof |
| 08/11/2005 | WO2004004662A3 Compositions and methods for the diagnosis and treatment of tumor |
| 08/11/2005 | WO2003087762A3 Methyl-cpg binding domain protein 2 homologs |
| 08/11/2005 | WO2003087377A9 Insecticide proteins from photorabdus luminescens |
| 08/11/2005 | WO2003077836A3 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 08/11/2005 | WO2003076634A3 Transcriptional regulation of ptp-1b |
| 08/11/2005 | WO2003062446A3 Mrp9 and its use detecting and treating cancer |
| 08/11/2005 | WO2003054148A3 Zinc finger-based drug-dependent gene regulation system |
| 08/11/2005 | WO2003035858A3 Bacterial polypeptides involved in nucleic acid processing |
| 08/11/2005 | US20050177901 Expression vector comprising nucleotide sequences coding proteins associated with carbohydrate metabolism, degradation and biosynthesis for use in enhancement of nutrient quality of crop plants |
| 08/11/2005 | US20050177900 Impartment of virus-resistance with the use of plant protein binding to plant virus transport protein |
| 08/11/2005 | US20050177898 Maize metallothionein 2 promoter and methods of use |
| 08/11/2005 | US20050177897 Isolated nucleic acid molecule of a nucleotide sequence for promoters that initiate transcription |
| 08/11/2005 | US20050177893 Transcription factors and methods for introduction of value-added seed traits and stress tolerance |
| 08/11/2005 | US20050177892 Maize Rar1-interactor polynucleotides and methods of use |
| 08/11/2005 | US20050177887 Cells homozygous for pituitary tumor transforming gene (PTTG) mutation for use as models in diagnosis, prevention and treatment of blood, pancreatic and fertility disorders |
| 08/11/2005 | US20050177886 T1R3 transgenic animals, cells and related methods |
| 08/11/2005 | US20050177885 CCN1 transgenic animals |
| 08/11/2005 | US20050177884 Chimeric nonhuman animal |
| 08/11/2005 | US20050177879 Using nuclear transplantation to generate animal which express human growth hormone in mammary glands; bioreactors |
| 08/11/2005 | US20050177878 Process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
| 08/11/2005 | US20050177877 Process for producing physiologically active protein using genetically modified silkworm |
| 08/11/2005 | US20050177876 Fcyriia transgenic animal model for autoimmune disease |
| 08/11/2005 | US20050176947 Optical recording apparatus using one-dimensional diffractive light modulator |
| 08/11/2005 | US20050176946 Constitutive promoter from Arabidopsis |
| 08/11/2005 | US20050176945 Cloning and characterization of slc26a7 and slc26a9 anion exchangers |
| 08/11/2005 | US20050176944 Intracellular signaling polypeptide for identifying modulator for prevention and treatment cell proliferative, endocrine, autoimmune/inflammatory, neurological, gastrointestinal, reproductive, developmental, and vesicle trafficking disorders |
| 08/11/2005 | US20050176943 Nucleotide sequences coding sperm maturation polypeptides for identifying modulators for treatment and prevention of male sterility |
| 08/11/2005 | US20050176942 Diagnostic tests for a new spirochete, Borrelia lonestari sp. nov. |
| 08/11/2005 | US20050176931 Eotaxin : eosinophil chemotactic cytokine |
| 08/11/2005 | US20050176930 Nucleotide sequences coding tumor associated antigen for use in diagnosis, prevention and treatment of cell proliferative disorders; mimetics; antitumor agents |
| 08/11/2005 | US20050176929 Hiv-1 subtype isolate regulatory/accessory genes, and modifications and derivatives thereof |
| 08/11/2005 | US20050176928 Insect nuclear receptor genes and uses thereof |
| 08/11/2005 | US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis |
| 08/11/2005 | US20050176926 Specific detection of proteolytic enzymes |
| 08/11/2005 | US20050176826 Use of asc-1 inhibitors to treat neurological and psychiatric disorders |
| 08/11/2005 | US20050176660 Use of specific antisense-based constructs and peptide-specific polyclonal and monoclonal antibodies in leukemia, acute or chronic tissue damages, HIV-related damage of brain or other tissues, skeletal muscle disorders, transplantation rejection; Parkinson's disease; amyotrophic lateral sclerosis |
| 08/11/2005 | US20050176659 Polypeptide contributing to regulating the metabolism of triglycerides; obesity as well as related disorders such as eating disorder, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, dyslipidemia, osteoarthritis, gallstone, cancers of the reproductive organs |
| 08/11/2005 | US20050176641 Long lasting natriuretic peptide derivatives |